NCT01867736View on ClinicalTrials.gov

BIOLUX P-II First-in-Man Study to Compare the Passeo-18 Lux DRB Against POBA in Infrapopliteal Arteries

NACompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

July 31, 2014

Conditions
AtherosclerosisArteriosclerosisVascular DiseasePeripheral Artery Disease
Interventions
DEVICE

Passeo-18 Lux DRB

DEVICE

Standard PTA (POBA)

Trial Locations (6)

Unknown

Medical University of Graz, Graz

Imelda Hospital, Bonheiden

A.Z. Sint-Blasius, Dendermonde

Universitäts-Herzzentrum Freiburg, Bad Krozingen

Gefaesszentrum Berlin, Medizinische Klinik, Ev. Krankenhaus Königin Elisabeth Herzberge, Berlin

Parkkrankenhaus Leipzig Südost GmbH, Leipzig

Sponsors

Lead Sponsor

Biotronik AG
All Listed Sponsors
lead

Biotronik AG

INDUSTRY

NCT01867736 - BIOLUX P-II First-in-Man Study to Compare the Passeo-18 Lux DRB Against POBA in Infrapopliteal Arteries | Biotech Hunter | Biotech Hunter